Literature DB >> 20093593

Clinical decision making using ovarian cancer risk assessment.

Michael P Stany1, G Larry Maxwell, G Scott Rose.   

Abstract

OBJECTIVE: Although any adnexal abnormality found at imaging can be concerning for an ovarian malignancy, the clinician must perform an evaluation to decide if the actual likelihood of malignancy justifies the risk of surgery. When determining the likelihood of an asymptomatic, incidental adnexal mass being malignant, the provider must answer one important question: Do the clinical findings warrant the potential morbidity of surgery? This article will focus on the decision making that goes into such an evaluation.
CONCLUSION: A patient's medical history, physical examination, CA-125 level, and imaging characteristics are all factors that impact the ultimate decision of whether a patient can be observed with repeat imaging or should proceed to surgical evaluation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20093593     DOI: 10.2214/AJR.09.3669

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  3 in total

1.  Circulating interleukin-8 and plasminogen activator inhibitor-1 are increased in women with ovarian carcinoma.

Authors:  Guro Aune; Astrid Kamilla Stunes; Aina-Mari Lian; Janne Elin Reseland; Solveig Tingulstad; Sverre H Torp; Unni Syversen
Journal:  Results Immunol       Date:  2012-11-02

2.  Diagnostic value of ultrasound indicators of neoplastic risk in preoperative differentiation of adnexal masses.

Authors:  Nabil Abdalla; Michał Bachanek; Seweryn Trojanowski; Krzysztof Cendrowski; Włodzimierz Sawicki
Journal:  J Ultrason       Date:  2013-06-30

3.  Ovarian microcystic stromal tumor: Radiologic-pathologic correlation.

Authors:  Daniel Jeong; Ardeshir Hakam; Mohammad Abuel-Haija; Hye Sook Chon
Journal:  Gynecol Oncol Rep       Date:  2018-05-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.